Print FriendlySIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 125.68 |
| Enterprise Value ($M) | 623.08 |
| Book Value ($M) | -27.47 |
| Book Value / Share | -0.67 |
| Price / Book | -4.58 |
| NCAV ($M) | -357.64 |
| NCAV / Share | -8.74 |
| Price / NCAV | -0.35 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.63 |
| Return on Assets (ROA) | -0.32 |
| Return on Equity (ROE) | -1.20 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.70 |
| Current Ratio | 3.91 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 353.56 |
| Assets | 683.74 |
| Liabilities | 711.21 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 478.78 |
| Operating Income | -16.66 |
| Net Income | -363.48 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 60.85 |
| Cash from Investing | -14.80 |
| Cash from Financing | -92.17 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | BlackRock Inc. | 1.60 | -87.18 | |
| 13G/A | D. E. Shaw & Co, L.p. | 4.50 | -44.70 | |
| 13G/A | Lsv Asset Management | 4.54 | -9.80 | |
| 13G/A | Vanguard Group Inc | 5.53 | -2.32 | |
| 13G/A | Highbridge Capital Management Llc | 5.32 | 9.98 | |
| 13G/A | Jpmorgan Chase & Co | 8.30 | 26.49 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| Quarterly Report – 10-Q | ||
| Quarterly Report – 10-Q | ||
| Quarterly Report – 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 30,505 | 229,073 | 13.32 | |
| 75,287 | 524,083 | 14.37 | |
| 68,364 | 404,033 | 16.92 | |
| 40,832 | 342,562 | 11.92 | |
| 95,218 | 560,324 | 16.99 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| ELAT – Elanco Animal Health Incorporated 5.00% Tangible Equity Units | GSK – GlaxoSmithKline plc |
| JNJ – Johnson & Johnson | LLY – Eli Lilly And Co |
| MRK – Merck & Co., Inc. |
Financial data and stock pages provided by
Fintel.io
